Announced on | Meeting on |
Aug 05, 2024 | Aug 10, 2024 |
Quarterly Results | |
May 07, 2024 | May 13, 2024 |
Audited Results | |
Nov 03, 2023 | Nov 09, 2023 |
Quarterly Results | |
Aug 07, 2023 | Aug 12, 2023 |
Quarterly Results | |
May 23, 2023 | May 27, 2023 |
Audited Results |
Pentokey Organy (India) Share Price
- OpenN.A.
- HighN.A.
- LowN.A.
- Prev CloseN.A.
- VolumeN.A.
- VWAP(₹)N.A.
Pentokey Organy share price insights
Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 3.25% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)Pentokey Organy Share Price Update
Pentokey Organy (India) Ltd. share price moved down by -1.40% from its previous close of Rs 54.66. Pentokey Organy (India) Ltd. stock last traded price is 53.89
Share Price Value Today/Current/Last 53.89 Previous Day 54.66
Pentokey Organy Share Price Returns
1 Day | -1.4% |
1 Month | 10.07% |
3 Months | 20.32% |
1 Year | 19.04% |
3 Years | 163.52% |
5 Years | 498.78% |
Key Metrics
PE Ratio(x) | 66.58 |
EPS - TTM(₹) | 0.78 |
MCap(₹ Cr.) | 32.62 |
MCap Rank | 148 |
PB Ratio(x) | 3.69 |
Div Yield(%) | 0.00 |
Face Value(₹) | 10.00 |
52W High(₹) | 129.75 |
52W Low(₹) | 38.00 |
MCap/Sales | 7.99 |
Beta(1 Month) | -0.17 |
BV/Share(₹) | 14.77 |
Pentokey Organy Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Pentokey Organy News & Analysis
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
AnnouncementsAnnouncement under Regulation 30 (LODR)-Newspaper Publication
Announcements37Th Annual General Meeting On 28Th September, 2024
AnnouncementsAnnouncement under Regulation 30 (LODR)-Change in Management
Announcements
Pentokey Organy Financials
Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 0.13 0.12 0.14 2.18 2.41 Total Income Growth (%) 8.96 -14.84 -93.57 -9.42 236.84 Total Expenses 0.08 0.07 0.10 1.82 1.97 Total Expenses Growth (%) 15.62 -28.08 -94.54 -7.50 303.60 EBIT 0.05 0.05 0.04 0.36 0.43 EBIT Growth (%) -1.05 17.78 -88.62 -18.13 92.39 Profit after Tax (PAT) 0.05 0.05 0.04 0.36 0.43 PAT Growth (%) -3.56 17.78 -88.62 -16.99 117.12 EBIT Margin (%) 36.28 39.95 28.89 16.32 18.05 Net Profit Margin (%) 35.36 39.95 28.89 16.32 17.80 Basic EPS (₹) 0.07 0.08 0.06 0.57 0.68 All figures in Rs Cr, unless mentioned otherwise
InsightsEmployee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 3.25% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 9.51 8.92 5.25 5.51 6.09 Total Assets Growth (%) 6.61 69.90 -4.72 -9.52 -11.87 Total Liabilities 0.24 0.54 0.05 0.15 0.50 Total Liabilities Growth (%) -55.56 980.00 -66.67 -70.00 -43.18 Total Equity 9.26 8.38 5.20 5.36 5.59 Total Equity Growth (%) 10.50 61.15 -2.99 -4.11 -7.45 Current Ratio (x) 37.10 15.77 93.82 38.45 11.72 Total Debt to Equity (x) 0.00 0.00 0.00 0.00 0.00 Contingent Liabilities 0.00 1.72 - - - All figures in Rs Cr, unless mentioned otherwise
InsightsZero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 0.55 -0.10 -0.42 0.56 0.86 Net Cash used in Investing Activities -0.59 0.19 0.23 -0.55 -0.89 Net Cash flow from Financing Activities -0.01 -0.03 - - - Net Cash Flow -0.04 0.06 -0.19 0.01 -0.03 Closing Cash & Cash Equivalent 0.07 0.11 0.05 0.24 0.24 Closing Cash & Cash Equivalent Growth (%) -39.08 116.96 -78.53 3.62 -12.48 Total Debt/ CFO (x) 0.00 0.00 0.00 0.00 0.00 All figures in Rs Cr, unless mentioned otherwise
InsightsCash from Operations vs PAT
Operating cash flow of Rs 0.55 cr is 0.63 times compared to the reported net profit of Rs 0.87 cr. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 9.41 37.89 -3.14 -4.48 -7.87 Return on Capital Employed (%) 9.48 38.23 -3.14 -4.46 -7.84 Return on Assets (%) 9.17 35.59 -3.11 -4.36 -7.23 Interest Coverage Ratio (x) 146.90 112.56 0.00 0.00 0.00 Asset Turnover Ratio (x) 0.48 0.62 - 0.01 25.63 Price to Earnings (x) 40.32 8.20 -69.44 -28.49 -9.55 Price to Book (x) 3.79 3.11 2.18 1.27 0.75 EV/EBITDA (x) 33.64 6.68 -43.29 -9.37 -0.92 EBITDA Margin (%) 20.04 73.48 0.00 0.00 -28.13
Peer Comparison
NAME 1D 1W 1M 3M 1Y 3Y 5Y Pentokey Organy Stock Performance -1.40 -12.77 9.76 14.32 24.98 0.00 498.78 India Glycols Stock Performance 7.67 8.01 16.57 80.85 80.01 91.89 633.84 Kanoria Chem Stock Performance -2.03 1.17 -1.03 8.12 -3.10 -17.50 209.39 Ashok Alco-Chem Stock Performance 0.57 -1.20 9.04 29.70 19.72 58.85 517.88 All values in %
Mutual Funds Ownership
No Data Available
Corporate Actions
Board Meeting
Quarterly Results
Aug 05, 2024
Board Meeting
Audited Results
May 07, 2024
Board Meeting
Quarterly Results
Nov 03, 2023
Announced on Ex-Date Dividend% May 23, 2013 Aug 05, 2013 10% May 31, 2012 Aug 09, 2012 10% Announced on Ex-Date Nov 06, 2012 Dec 13, 2012 Bonus Ratio: 2 share(s) for every 3 shares held No Data Available
Announced on Ex-Date Nov 16, 1994 - Rights ratio: 1 share for every 2 held at a price of Rs 10.0 Announced on Meeting on Sep 15, 2023 Sep 29, 2023 A.G.M. Aug 12, 2021 Sep 28, 2021 - Aug 11, 2020 Sep 29, 2020 - Aug 07, 2019 Sep 26, 2019 Book closure from Sep 20, 2019 to Sep 26, 2019 Aug 02, 2018 Sep 21, 2018 Book closure from Sep 15, 2018 to Sep 21, 2018
About
Pentokey Organy (India) Ltd., incorporated in the year 1986, is a Small Cap company (having a market cap of Rs 34.19 Crore) operating in Chemicals sector.
Pentokey Organy (India) Ltd. key Products/Revenue Segments include Pharmaceutical Products for the year ending 31-Mar-2023.
For the quarter ended 30-06-2024, the company has reported a Standalone Total Income of Rs .13 Crore, up 8.96 % from last quarter Total Income of Rs .12 Crore and down 94.60 % from last year same quarter Total Income of Rs 2.41 Crore. Company has reported net profit after tax of Rs .05 Crore in latest quarter.
The company’s top management includes Mr.Rajendra Gujrathi, Mr.Arun Goenka, Mr.Kostuv Kejriwal, Mr.Purshottam Kejriwal, Mr.Devendra Shrimanker, Ms.Prajakta Shidhore, Ms.Divya Desai. Company has Verma Mehta & Associates as its auditors. As on 30-06-2024, the company has a total of .63 Crore shares outstanding.
About Pentokey Organy
Pentokey Organy (India) Ltd., incorporated in the year 1986, is a Small Cap company (having a market cap of Rs 34.19 Crore) operating in Chemicals sector. Pentokey Organy (India) Ltd. key Products/Revenue Segments include Pharmaceutical Products for the year ending 31-Mar-2023.For the quarter ended 30-06-2024, the company has reported a Standalone Total Income of Rs .13 Crore, up 8.96 % from last quarter Total Income of Rs .12 Crore and down 94.60 % from last year same quarter Total Income of Rs 2.41 Crore. Company has reported net profit after tax of Rs .05 Crore in latest quarter.The company’s top management includes Mr.Rajendra Gujrathi, Mr.Arun Goenka, Mr.Kostuv Kejriwal, Mr.Purshottam Kejriwal, Mr.Devendra Shrimanker, Ms.Prajakta Shidhore, Ms.Divya Desai. Company has Verma Mehta & Associates as its auditors. As on 30-06-2024, the company has a total of .63 Crore shares outstanding.
Key Indices Listed On
-
Address
509, Western Edge I,Off Western Express Highway,Borivali East,Mumbai, Maharashtra - 400066
Executive Leadership
Rajendra Gujrathi
Chief Executive OfficerArun Goenka
Non Exe.Non Ind.DirectorKostuv Kejriwal
Non Exe.Non Ind.DirectorPurshottam Kejriwal
Non Exe.Non Ind.DirectorAuditors
Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.